XORTX Therapeutics XRTX
NASDAQ XRTX
$0.93 -0.06 (-6.05%)
At close: Oct 21, 2026 · 4:00 PM EDT

XORTX Therapeutics (XRTX) Other Non-Current Liabilities (2020 - 2026)

Updated

XORTX Therapeutics' Other Non-Current Liabilities came in at $1,000 for the quarter ended Jun 30, 2026, down 99.4% from $177,000 a year earlier and unchanged from the prior quarter.

Analysis

XORTX Therapeutics (XRTX) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends

As of Dec 31, 2025, XORTX Therapeutics' Other Non-Current Liabilities was $8,000, down 98.6% from the prior year.

  • Other Non-Current Liabilities carries a four-year compound annual growth rate of -83.2% (years ended Dec 2021 to Dec 2025).
  • Going back by year, Other Non-Current Liabilities was $572,000 in the year ended Dec 31, 2024 (+7.7%), $531,000 in the year ended Dec 31, 2023 (-86.2%), $3.85 million in the year ended Dec 31, 2022 (-61.8%) and $10.08 million in the year ended Dec 31, 2021.
  • The five-year range for quarterly Other Non-Current Liabilities is $1,000 (the quarter ended Mar 31, 2026) to $9.02 million (the quarter ended Sep 30, 2021).
  • Year-over-year, Other Non-Current Liabilities has declined for six consecutive quarters, with an average decline of 80.1% over the last seven quarters.
  • The fastest year-over-year change in Other Non-Current Liabilities over five years came in the quarter ended Mar 31, 2022 (growth of 42.6%), and the weakest in the quarter ended Mar 31, 2026 (a decline of 99.7%).
  • Business Quant data shows XRTX's Other Non-Current Liabilities at $1,000 (quarter ended Mar 31, 2026), $8,000 (quarter ended Dec 31, 2025) and $101,000 (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 XORTX Therapeutics 893,236.25 -2.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1,000.00
Mar 31, 2026 1,000.00
Dec 31, 2025 8,000.00
Sep 30, 2025 101,000.00
Jun 30, 2025 177,000.00
Mar 31, 2025 326,000.00
Dec 31, 2024 572,000.00
Sep 30, 2024 1.33 Mn
Jun 30, 2024 1.57 Mn
Mar 31, 2024 3.22 Mn
Dec 31, 2023 531,000.00
Sep 30, 2023 24,746.00
Jun 30, 2023 24,746.00
Mar 31, 2023 24,746.00
Dec 31, 2022 3.85 Mn
Sep 30, 2022 1.66 Mn
Jun 30, 2022 2.13 Mn
Mar 31, 2022 3.35 Mn
Dec 31, 2021 3.61 Mn
Sep 30, 2021 8.90 Mn
API Access

XORTX Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=XRTX&period=max&api_key=YOUR_API_KEY